Jun 2026 (Q1 FY27) — Aug 6, 2026
Prestige Consumer Healthcare Q1 FY27 — Strong Start with Strategic Acquisitions and Record Free Cash Flow
Read the full callPrestige Consumer Healthcare (PBH) earnings
- Jun 2026
- Jun 2026 (Q1 FY27)
- Mar 2026
Prestige Consumer Healthcare earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 266 | +6.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 19.8 | −9.0 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 29.2 | −38.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$49.71 −0.42% · −$0.21
Performance −19.9% 1Y
1Y: $62.09 on 17 Oct 2025 → $49.71. High $70.21 (26 Feb 2026), low $44.77 (1 Oct 2026).
- Previous close
- $49.92
- 52-week range
- $44.77 – $70.21
- One year
- −20.05%
Overview
- Symbol
- PBH
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Prestige Consumer Healthcare earnings calls (PBH)
Financials
What the filings say
Net profit, year on year: −39% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 284 | 290 | 297 | 250 | 274 | 283 | 282 | 266 |
| Operating profit | 84 | 92 | 88 | 72 | 80 | 82 | 75 | 53 |
| Operating margin | 29.7% | 31.7% | 29.8% | 28.8% | 29.1% | 29.1% | 26.8% | 19.8% |
| Net profit | 54 | 61 | 50 | 47 | 42 | 47 | 54 | 29 |
| EPS ($ per share) | 1.10 | 1.23 | — | 0.96 | 0.86 | 0.98 | — | 0.61 |
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | 702 | 844 | 1,009 | 1,214 | 1,132 | 1,341 | 1,556 | 1,746 |
| Total liabilities | 2,345 | 2,343 | 2,071 | 2,093 | 1,907 | 1,663 | 1,567 | 1,607 |
| Fixed assets | 51 | 56 | 70 | 71 | 70 | 77 | 75 | 122 |
| Total assets | 3,441 | 3,514 | 3,429 | 3,671 | 3,354 | 3,318 | 3,402 | 3,494 |
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 189 | 217 | 236 | 260 | 230 | 249 | 252 | 258 |
| Cash from investing | 55 | -17 | -22 | -257 | -12 | -20 | -17 | -137 |
| Cash from financing | -249 | -131 | -279 | -8 | -186 | -241 | -182 | -156 |
| Net cash flow | -5 | 67 | -62 | -5 | 31 | -12 | 51 | -34 |
| Capital expenditure | -10 | -15 | -22 | -10 | -8 | -10 | -8 | -11 |
| Free cash flow | 179 | 203 | 213 | 250 | 222 | 239 | 243 | 246 |
Insider filings
41 filings between Nov 25, 2025 and Aug 4, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$424.4K
8 sales by 2 insiders
63% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 16
- Award — granted as compensation
- 17
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Zerillo Jeffrey | — | $246.4K | May 11, 2026 |
| BYOM JOHN E | — | $178.1K | Nov 25, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 4, 2026 | ZIER DAWN M. Director | Award | 2,981 | $0 |
| Aug 4, 2026 | BYOM JOHN E Director | Award | 2,981 | $0 |
| Aug 4, 2026 | Clark Celeste A. Director | Award | 2,981 | $0 |
| Aug 4, 2026 | DArecca James Director | Award | 2,981 | $0 |
| Aug 4, 2026 | Kelly John F. Director | Award | 2,981 | $0 |
| May 11, 2026 | Zerillo Jeffrey Senior VP Operations | Sale 10b5-1 plan | 351 | $18.4K |
| May 7, 2026 | Zerillo Jeffrey Senior VP Operations | Tax withheld 10b5-1 plan | 351 | $19.2K |
| May 7, 2026 | Sacco Christine CFO & COO | Tax withheld | 991 | $54.1K |
| May 7, 2026 | Mekhail Adel EVP, Marketing & Sales | Tax withheld | 487 | $26.6K |
| May 7, 2026 | Zerillo Jeffrey Senior VP Operations | Sale 10b5-1 plan | 305 | $16.6K |
| May 7, 2026 | Lombardi Ronald M. Chief Executive Officer | Tax withheld | 2,543 | $138.8K |
| May 5, 2026 | Zerillo Jeffrey Senior VP Operations | Sale | 1,207 | $66.4K |
| May 5, 2026 | Lombardi Ronald M. Chief Executive Officer | Tax withheld | 2,197 | $122.5K |
| May 5, 2026 | Zerillo Jeffrey Senior VP Operations | Tax withheld | 307 | $17.1K |
| May 5, 2026 | Sacco Christine CFO & COO | Tax withheld | 1,267 | $70.6K |
| May 5, 2026 | Zerillo Jeffrey Senior VP Operations | Sale 10b5-1 plan | 346 | $19.1K |
| May 4, 2026 | Sacco Christine CFO & COO | Award | 7,008 | $0 |
| May 4, 2026 | P'Pool William See Remarks | Award | 4,187 | $0 |
| May 4, 2026 | P'Pool William See Remarks | Tax withheld | 1,888 | $104.4K |
| May 4, 2026 | P'Pool William See Remarks | Award | 3,675 | $0 |
| May 4, 2026 | Zerillo Jeffrey Senior VP Operations | Tax withheld 10b5-1 plan | 1,243 | $68.8K |
| May 4, 2026 | Zerillo Jeffrey Senior VP Operations | Award 10b5-1 plan | 2,857 | $0 |
| May 4, 2026 | Zerillo Jeffrey Senior VP Operations | Award 10b5-1 plan | 2,450 | $0 |
| May 4, 2026 | Mekhail Adel EVP, Marketing & Sales | Award | 4,014 | $0 |
| May 4, 2026 | Mekhail Adel EVP, Marketing & Sales | Award | 3,505 | $0 |
| May 4, 2026 | Mekhail Adel EVP, Marketing & Sales | Tax withheld | 1,695 | $93.8K |
| May 4, 2026 | Lombardi Ronald M. Chief Executive Officer | Award | 19,662 | $0 |
| May 4, 2026 | Lombardi Ronald M. Chief Executive Officer | Award | 31,468 | $0 |
| May 4, 2026 | Sacco Christine CFO & COO | Award | 11,976 | $0 |
| May 4, 2026 | Sacco Christine CFO & COO | Tax withheld | 3,434 | $189.9K |
| May 4, 2026 | Lombardi Ronald M. Chief Executive Officer | Tax withheld | 16,789 | $928.6K |
| May 2, 2026 | Sacco Christine CFO & COO | Tax withheld | 1,091 | $60.1K |
| May 2, 2026 | Mekhail Adel EVP, Marketing & Sales | Tax withheld | 542 | $29.9K |
| May 2, 2026 | Zerillo Jeffrey Senior VP Operations | Tax withheld | 432 | $23.8K |
| May 2, 2026 | P'Pool William See Remarks | Tax withheld | 599 | $33.0K |
| May 2, 2026 | Lombardi Ronald M. Chief Executive Officer | Tax withheld | 2,665 | $146.8K |
| Feb 11, 2026 | Zerillo Jeffrey Senior VP Operations | Sale | 1,000 | $65.9K |
| Jan 6, 2026 | Rosado Jose Luis See Remarks | Award | 3,426 | $0 |
| Dec 1, 2025 | Zerillo Jeffrey Senior VP Operations | Sale 10b5-1 plan | 281 | $16.9K |
| Nov 28, 2025 | Zerillo Jeffrey Senior VP Operations | Sale 10b5-1 plan | 719 | $43.1K |
| Nov 25, 2025 | BYOM JOHN E Director | Sale | 3,000 | $178.1K |
| Aug 5, 2025 | BYOM JOHN E Director | Award | 2,094 | $0 |
| Aug 5, 2025 | Kelly John F. Director | Award | 2,094 | $0 |
| Aug 5, 2025 | ZIER DAWN M. Director | Award | 2,094 | $0 |
| Aug 5, 2025 | Hopkins Sheila Director | Award | 2,094 | $0 |
| Aug 5, 2025 | DArecca James Director | Award | 2,094 | $0 |
| Aug 5, 2025 | Clark Celeste A. Director | Award | 2,094 | $0 |
| May 7, 2025 | Mekhail Adel EVP, Marketing & Sales | Tax withheld | 457 | $37.2K |
| May 7, 2025 | Zerillo Jeffrey Senior VP Operations | Tax withheld | 354 | $28.8K |
| May 7, 2025 | Fritz Mary Beth SVP Quality & Regulatory | Tax withheld | 315 | $25.6K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Prestige Consumer Healthcare Inc.
Free account. Everything above stays public.
Write why you follow Prestige Consumer Healthcare Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading